Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity
NCT06909201
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
DRUG:
HP 129Xe MRI
Sponsor
M.D. Anderson Cancer Center